I
Immunovant, Inc. (IMVT)
NMS – Real vaqt narxi. Valyuta: USD
23.98
-1.38 (-5.44%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
23.84
-0.14 (-0.56%)
Bozordan keyin: Mar 27, 2026, 6:31 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
NMS – Real vaqt narxi. Valyuta: USD
23.98
-1.38 (-5.44%)
Yopilishda: Mar 27, 2026, 4:00 PM EDT
23.84
-0.14 (-0.56%)
Bozordan keyin: Mar 27, 2026, 6:31 PM EDT
Immunovant, Inc., klinik davrlagidagi immunologiya kompaniyasi, autoimmun kasalliklarni davolash uchun monoklonal antitelalarni ishlab chiqadi. Kompaniya Graves kasalligi, revmatoid artrit, miyasteniya gravis, surunkali yallig'lanishli demiyelinatsiya qiluvchi polinevropatiya, teri lyupus eritematoz kasalligi va Sjögren kasalligi uchun IMVT-1402; va miyasteniya gravis, surunkali yallig'lanishli demiyelinatsiya qiluvchi polinevropatiya va qalqonsimon ko'z kasalligi uchun batoklimabni ishlab chiqadi. Kompaniya 2018 yilda tashkil etilgan va Nyu-York, Nyu-Yorkda joylashgan. Immunovant, Inc. Roivant Sciences Ltd. kompaniyasining sho'ba korxonasi hisoblanadi.
| Ism | Lavozim |
|---|---|
| Dr. Eric Venker M.D., Pharm.D. | CEO & Director |
| Dr. Frank M. Torti M.B.A., M.D. | Executive Chairperson of the Board |
| Dr. Jay S. Stout M.S., Ph.D. | Chief Technology Officer |
| Dr. William L. Macias M.D., Ph.D. | CMO Emeritus |
| Mr. Andy Deig M.B.A. | Senior Vice President of Strategic Finance |
| Mr. Christopher A. Van Tuyl Esq., J.D. | Chief Legal Officer & Corporate Secretary |
| Mr. Tiago M. Girao CPA | Chief Financial Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2025-12-12 | 8-K | d68980d8k.htm |
| 2025-11-21 | 8-K | imvt-20251121.htm |
| 2025-11-10 | 8-K | imvt-20251110.htm |
| 2025-09-03 | 8-K | imvt-20250903.htm |
| 2025-08-28 | 8-K | imvt-20250827.htm |
| 2025-08-11 | 8-K | imvt-20250811.htm |
| 2025-07-29 | 8-K | imvt-20250728.htm |
| 2025-07-09 | DEFA14A | defa14aadditionalmaterials.htm |
| 2025-05-29 | 8-K | imvt-20250529.htm |
| 2025-04-30 | S-8 | imvt-20250430xsx8.htm |
| Ms. Christine Blodgett |
| Senior Vice President of Human Resources |
| Ms. Julie Kirschling | Senior Vice President of Program & Alliance Management |
| Ms. Melanie Gloria B.S.N. | Chief Operating Officer |